ResearcherThe University of OsakaNo recent work listed
Yuwei Liu
Matched on ORCID iD 0000-0003-0762-9840; OpenAlex author ID A5055631674. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. Co-author DOI 10.1007/s00259-021-05554-2↗
- Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models. First author DOI 10.2967/jnumed.119.233122↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tadashi Watabe · 2 shared papers, 2020–2022 · strength 0.23
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
- Frederik Lars Giesel · 2 shared papers, 2020–2022 · strength 0.23
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
- Jun Hatazawa · 2 shared papers, 2020–2022 · strength 0.23
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.